Search results for:

sucralfate

sucralfate
Brand names: Carafate
Form Strength
SUSPENSION, ORAL 1 g/10 mL
TABLET, ORAL 1 g
Display Protectants Class: 562832
Medication comments:
Enteral Drug Administration notes.
Generic
(Brand)		 Comments and Considerations Recommendations for Administration with Enteral Nutrition
sucralfate
(Carafate)		 Suspension may cause insoluble mass (bezoar) by binding to proteins. Minimal benefit with post-pyloric tubes. Do NOT administer through feeding tube. Do NOT use suspension. Recommend NexIUM or H2RA instead.
Last updated: Oct. 11, 2020
UpToDate Lexidrug

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.
Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved